Skip to content
FIND A HEALTH VALLEY ACTOR
Innosuisse

Innosuisse Supports 7 Promising Swiss Health Valley Startups 

05.09.2025
Share this article

Innosuisse has selected 39 new Startup Innovation Projects, providing direct funding to early-stage Swiss companies on the cusp of entering the market. These startups are driving innovation across diverse sectors, from pharma and life sciences to industrial applications and beyond. 7 are located in the Swiss Health Valley.

 

Through its Startup Innovation Projects programme, Innosuisse offers direct financial support to high-potential, science-based projects led by Swiss startups. The goal is to accelerate market readiness by bridging the critical gap between research and commercialization.

Unlike traditional innovation grants, this program funds startups exclusively, without requiring a research partner. To qualify, companies must:

  • Be headquartered in Switzerland
  • Have been founded within the past five years
  • Employ fewer than 50 full-time equivalents (FTEs)
  • Focus on application-oriented research that prepares them for their first market entry

Between October 2024 and July 2025, 39 startups were selected to receive this boost. Among them are several exciting projects from the Swiss Health Valley, reflecting the region’s strength in life sciences, medtech, and digital health innovation. These projects aim to bring transformative solutions to patients and healthcare systems worldwide.

 

The recipients are:

Twiice | Renens, 2020 – advanced wearable robotics, particularly powered exoskeletons designed for walking assistance and rehabilitation of people with mobility disorders

Nagi bioscience | Saint-Sulpice (VD), 2018 – advancing drug discovery for Parkinson’s and other neurodegenerative diseases through automated, high throughput and scalable c. Elegans screening

Rea diagnostics | Ecublens (VD), 2022 – clinical validation of the first self-test to diagnose preterm birth

Haya therapeutics | Epalinges, 2019 – RNA-guided programmable therapeutics targeting the regulatory genome to treat serious health conditions

Medirapp | Prilly (VD),2024 – transforming the global ultrasound diagnostics market with an AI-powered digital solution that boosts workflow efficiency and diagnostic accuracy.

Hero support | Veyrier (GE), 2022 – cutting-edge 3D printed devices transforming radiation therapy

Tune insight | Ecublens (VD), 2021 – encrypted computing technology that enables secure, privacy-preserving data collaborations and collective analytics across organizations without sharing raw data, a technology that is especially relevant for life sciences and digital health projects.

 

➡️ Source: Startupticker